Topic
HIDA scan
💡 What You Need to Know
- Purpose of HIDA Scan: A Hepatobiliary Iminodiacetic Acid (HIDA) scan is a nuclear medicine imaging procedure used to diagnose problems of the liver, gallbladder, and bile ducts.
- How it Works: A radioactive tracer is injected into a vein, travels to the liver, is excreted into the bile, and then flows into the gallbladder and small intestine. Images are taken to track its movement.
- Primary Indications: Commonly performed to evaluate for acute cholecystitis (gallbladder inflammation), chronic cholecystitis, bile duct obstruction, and biliary atresia in infants.
- Assessment of Gallbladder Function: Can assess the gallbladder's ejection fraction (how well it contracts and empties bile) in response to a fatty meal or cholecystokinin (CCK) stimulation.
🤒 Associated Symptoms
- Right Upper Quadrant Pain: Acute or chronic pain in the upper right abdomen, often radiating to the back or shoulder, especially after fatty meals.
- Nausea and Vomiting: Persistent feelings of sickness and emesis, particularly associated with abdominal discomfort.
- Jaundice: Yellowing of the skin or eyes, indicating potential bile duct obstruction or liver dysfunction.
- Fever and Chills: Systemic signs of inflammation or infection, such as in acute cholecystitis.
- Unexplained Abdominal Discomfort: Persistent or recurrent discomfort in the upper abdomen without a clear diagnosis from other imaging.
🛡 Crucial Precautions
- Pregnancy and Breastfeeding: Inform your physician if you are pregnant, suspect you might be pregnant, or are breastfeeding, as the radioactive tracer can pose risks.
- Fasting Requirements: Strict adherence to fasting guidelines (typically 4-6 hours NPO) is critical for accurate results; eating can cause the gallbladder to contract prematurely.
- Medication Review: Discuss all current medications with your doctor, especially opioids (e.g., morphine), as they can affect the sphincter of Oddi and alter scan results.
- Recent Barium Studies: Inform the department if you have had recent barium studies, as residual barium can interfere with image quality.
- Allergies: Report any known allergies, particularly to medications or contrast agents, though reactions to HIDA tracers are rare.
🍽 Dietary Directions & Restrictions
- Pre-Procedure Fasting: You must be NPO (nothing by mouth) for 4-6 hours prior to the scan. This includes food, drink, and chewing gum.
- Avoid Fatty Foods: For at least 24 hours before the fasting period, avoid consuming fatty foods, as this can cause the gallbladder to empty and affect the scan's sensitivity.
- Hydration (Limited): Small sips of water may be permitted up to 2 hours before the scan, but confirm with the imaging department.
- Post-Procedure Diet: Unless otherwise instructed, you can resume your normal diet immediately after the scan.
⚠️ Attendant Guidelines
- Duration of Scan: The scan typically takes 1-2 hours, but may extend to 3-4 hours or even 24 hours if delayed images are required.
- Remain Still: It is crucial to remain as still as possible during imaging to ensure clear and accurate pictures.
- Radiation Exposure: The radiation dose from a HIDA scan is minimal and considered safe, similar to that of a standard X-ray.
- Tracer Excretion: The radioactive tracer will naturally leave your body through urine and stool within 24 hours. Drink plenty of fluids to help flush it out.
- Potential for CCK Administration: If gallbladder ejection fraction is being assessed, a medication called cholecystokinin (CCK) may be administered, which can cause temporary abdominal cramping or nausea.
🩺 Physician's Perspective
- Diagnostic Accuracy: HIDA scans are highly sensitive for acute cholecystitis, especially when performed within 72 hours of symptom onset.
- Interpretation of Results: Non-visualization of the gallbladder suggests cystic duct obstruction (e.g., gallstones), while delayed visualization may indicate chronic cholecystitis.
- Ejection Fraction Significance: A low gallbladder ejection fraction (typically <35-40%) after CCK stimulation can indicate biliary dyskinesia or chronic acalculous cholecystitis.
- Differential Diagnosis: Results must be correlated with clinical symptoms, physical examination, and other imaging (e.g., ultrasound) to differentiate from other causes of abdominal pain.
- Follow-up Care: Abnormal findings often necessitate further evaluation, medical management, or surgical consultation (e.g., cholecystectomy).
🎓 Academic & Nursing Corner
- Patient Education: Provide clear instructions on fasting, medication restrictions, and what to expect during the procedure to alleviate anxiety.
- IV Access: Ensure secure intravenous access for the administration of the radiopharmaceutical and potentially CCK.
- Monitoring for Reactions: Although rare, monitor for any signs of allergic reaction to the tracer or adverse effects from CCK administration.
- Post-Procedure Care: Advise patients to increase fluid intake to aid in tracer excretion and to report any unusual symptoms.
- Documentation: Accurately document patient preparation, medication administration, patient tolerance, and any pertinent observations during the scan.
🔬 Clinical Reference Index
- Radiopharmaceutical: Technetium-99m-iminodiacetic acid (Tc-99m HIDA) or derivatives (e.g., mebrofenin, disofenin).
- Mechanism of Action: The tracer is taken up by hepatocytes and excreted into bile, allowing visualization of the hepatobiliary system.
- Normal Findings: Visualization of the liver, common bile duct, gallbladder, and small intestine within 60 minutes.
- Abnormal Findings (Acute Cholecystitis): Non-visualization of the gallbladder with visualization of the common bile duct and small intestine.
- Abnormal Findings (Chronic Cholecystitis/Biliary Dyskinesia): Delayed visualization of the gallbladder or a low gallbladder ejection fraction after CCK stimulation.
- Contraindications: Severe liver disease (may impair tracer uptake), pregnancy, and recent opioid use.